Your browser doesn't support javascript.
Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose.
Krantz, Matthew S; Kwah, Jason H; Stone, Cosby A; Phillips, Elizabeth J; Ortega, Gilbert; Banerji, Aleena; Blumenthal, Kimberly G.
  • Krantz MS; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Kwah JH; Yale School of Medicine, Section of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, New Haven, Connecticut.
  • Stone CA; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Phillips EJ; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Ortega G; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Banerji A; Division of Allergy and Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
  • Blumenthal KG; Harvard Medical School, Boston, Massachusetts.
JAMA Intern Med ; 181(11): 1530-1533, 2021 11 01.
Article in English | MEDLINE | ID: covidwho-1323839

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines Type of study: Experimental Studies / Observational study Topics: Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: JAMA Intern Med Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines Type of study: Experimental Studies / Observational study Topics: Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: JAMA Intern Med Year: 2021 Document Type: Article